AIDS Wasting in Women: Anabolic Effects of Testosterone

AIDS Wasting Syndrome Clinical Trial

Status Completed

Clinical Trial Summary

The study is a 6 month, placebo-controlled study of transdermal testosterone for women with HIV-associated weight loss. Women with AIDS wasting have been found to have low testosterone levels. This study is designed to test the efficacy of physiologic testosterone dosing to improve weight, muscle mass and quality of life indices, including energy level, appetite and libido, in androgen deficient women with AIDS wasting. After 6 months, all women receive open label transdermal testosterone for an additional 6 months.

Clinical Trial Description

n/a

Study Design

Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• AIDS Wasting Syndrome
• Cachexia
• HIV Wasting Syndrome

• NCT number: NCT00006158
• Study type: Interventional
• Source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Status: Completed
• Phase: Phase 2
• Start date: September 1998
• Completion date: December 2004